Heat Shock Protein 60 Overexpression is Associated with the Progression and Prognosis in Gastric Cancer

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Sep 11

PMID 25207654

Citations 45

Authors

Xiao-Shan Li

Qing Xu

Xiang-yang Fu

Wei-sheng Luo

Affiliations

Soon will be listed here.

Abstract

Background: Heat shock protein 60 (HSP60) is a chaperonin with essential functions for cell physiology and survival, and its expression correlates with prognosis in a number of malignancies. The aim of this study is to determine the relationship of HSP60 status with clinicopathological parameters and prognosis in gastric cancer.

Methods: The levels of HSP60 and matrix metallopeptidase 9 (MMP-9) antigen was evaluated by immunohistochemistry in 223 gastric carcinoma samples. The association between HSP60 and MMP-9, clinicopathological parameters, and prognosis of gastric cancer was examined.

Results: The level of HSP60 protein was significantly associated with depth invasion, lymph node metastasis and stage of disease (all P<0.05). Both univariate and multivariate analyses revealed that HSP60 was an independent prognostic factor for both overall survival (OS) and recurrence-free survival (RFS) (both P<0.05). Furthermore, HSP60 overexpression was associated with a poor prognosis in patients with advanced gastric cancer in different risk groups. Moreover, HSP60 was significantly correlated with MMP-9 among 223 gastric cancer tissues (P<0.001). Patients who had HSP60 overexpression, in which tumor cells displayed high invasiveness, had poor OS and shorter RFS.

Conclusion: HSP60 plays an important role on tumor aggressiveness and prognosis, and may act as a promising target for prognostic prediction.

Citing Articles

Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer.

Zheng M, Li S, Deng J, Huang C, Zhang H Int J Gen Med. 2025; 18():103-111.

PMID: 39801927 PMC: 11725283. DOI: 10.2147/IJGM.S499524.

Mitochondrial unfolded protein response-dependent β-catenin signaling promotes neuroendocrine prostate cancer.

Woytash J, Kumar R, Chaudhary A, Donnelly C, Wojtulski A, Bethu M Oncogene. 2024; .

PMID: 39690273 DOI: 10.1038/s41388-024-03261-4.

HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling.

Zhang Y, Pan R, Li K, Cheang L, Zhao J, Zhong Z Int J Biol Sci. 2024; 20(13):5162-5190.

PMID: 39430254 PMC: 11489178. DOI: 10.7150/ijbs.100015.

Proteostasis and Its Role in Disease Development.

Shukla M, Narayan M Cell Biochem Biophys. 2024; .

PMID: 39422790 DOI: 10.1007/s12013-024-01581-6.

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma.

Wang Q, Chen S, Wu Z, Ni J Front Oncol. 2024; 14:1415762.

PMID: 39224812 PMC: 11366582. DOI: 10.3389/fonc.2024.1415762.

References

Calderwood S, Khaleque M, Sawyer D, Ciocca D . Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci. 2006; 31(3):164-72. DOI: 10.1016/j.tibs.2006.01.006. View

Lin C, He P, Tsai N, Li C, Yang S, Hsu W . A potential role for Helicobacter pylori heat shock protein 60 in gastric tumorigenesis. Biochem Biophys Res Commun. 2010; 392(2):183-9. DOI: 10.1016/j.bbrc.2010.01.010. View

Cappello F, Di Stefano A, David S, Rappa F, Anzalone R, La Rocca G . Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer. 2006; 107(10):2417-24. DOI: 10.1002/cncr.22265. View

Chu D, Zhang Z, Li Y, Zheng J, Dong G, Wang W . Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer. 2010; 129(4):887-95. DOI: 10.1002/ijc.25734. View

Cappello F, Marino Gammazza A, Palumbo Piccionello A, Campanella C, Pace A, de Macario E . Hsp60 chaperonopathies and chaperonotherapy: targets and agents. Expert Opin Ther Targets. 2013; 18(2):185-208. DOI: 10.1517/14728222.2014.856417. View

Khalil A, James P . Biomarker discovery: a proteomic approach for brain cancer profiling. Cancer Sci. 2007; 98(2):201-13. PMC: 11158801. DOI: 10.1111/j.1349-7006.2007.00374.x. View

Cappello F, David S, Rappa F, Bucchieri F, Marasa L, Bartolotta T . The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer. 2005; 5:139. PMC: 1289279. DOI: 10.1186/1471-2407-5-139. View

Myung J, Afjehi-Sadat L, Felizardo-Cabatic M, Slavc I, Lubec G . Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci. 2004; 2(1):8. PMC: 543454. DOI: 10.1186/1477-5956-2-8. View

Faried A, Sohda M, Nakajima M, Miyazaki T, Kato H, Kuwano H . Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer. 2004; 40(18):2804-11. DOI: 10.1016/j.ejca.2004.08.013. View

10.

Dikken J, van Sandick J, Swellengrebel H, Lind P, Putter H, Jansen E . Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS). BMC Cancer. 2011; 11:329. PMC: 3175221. DOI: 10.1186/1471-2407-11-329. View

11.

Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y, Oue N . Molecular pathology of gastric cancer: research and practice. Pathol Res Pract. 2011; 207(10):608-12. DOI: 10.1016/j.prp.2011.09.006. View

12.

Pace A, Barone G, Lauria A, Martorana A, Palumbo Piccionello A, Pierro P . Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design. Curr Pharm Des. 2012; 19(15):2757-64. DOI: 10.2174/1381612811319150011. View

13.

Gupta R, Ramachandra N, Bowes T, Singh B . Unusual cellular disposition of the mitochondrial molecular chaperones Hsp60, Hsp70 and Hsp10. Novartis Found Symp. 2008; 291:59-68. DOI: 10.1002/9780470754030.ch5. View

14.

Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F . Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol. 2011; 17(3):290-9. PMC: 3022288. DOI: 10.3748/wjg.v17.i3.290. View

15.

Compare D, Rocco A, Nardone G . Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci. 2010; 14(4):302-8. View

16.

Cappello F, Di Stefano A, DAnna S, Donner C, Zummo G . Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol. 2005; 6(10):816. DOI: 10.1016/S1470-2045(05)70393-4. View

17.

Kampinga H, Hageman J, Vos M, Kubota H, Tanguay R, Bruford E . Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2008; 14(1):105-11. PMC: 2673902. DOI: 10.1007/s12192-008-0068-7. View

18.

Wang J, Cui S, Zhang X, Wu Y, Tang H . High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer. PLoS One. 2013; 8(4):e62876. PMC: 3637377. DOI: 10.1371/journal.pone.0062876. View

19.

Kim H, Hwang N, Lee K . Heat shock responses for understanding diseases of protein denaturation. Mol Cells. 2007; 23(2):123-31. View

20.

Edge S, Compton C . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17(6):1471-4. DOI: 10.1245/s10434-010-0985-4. View